Deciphering the Link Between Genetic Variants and Sphingolipid Metabolites in Fumonisin B1- and FTY720-Induced Neural Tube Defects
Loading...
Authors
Gardner, Nicole M.
Issue Date
2015-06-12
Volume
Issue
Type
Dissertation
Language
en_US
Keywords
Alternative Title
Abstract
Neural tube defects (NTDs) are birth defects that affect approximately 1/1000 babies annually worldwide and are thought to result from complex interactions between genetics, maternal nutrition, and environmental factors. Fumonisin B1 (FB1) is a mycotoxin produced by a common fungal contaminant of corn. Ingestion of FB1-contaminated food during early pregnancy is associated with increased risk for having a child with anencephaly/exencephaly, a lethal NTD. FB1 treatment of pregnant mice results in 79% exencephaly in LM/Bc mice, but less than 1% NTDs in SWV mice. |FB1 inhibits ceramide synthase (CerS1-6) enzymes involved in de novo sphingolipid biosynthesis, causing increased accumulation of sphinganine and its phosphorylated bioactive metabolite sphinganine-1-phosphate (Sa1P). CerS1 is the primary isoform found in the brain and has a unique bicistronic mRNA structure with Gdf1 (growth differentiation factor 1). Exome sequencing of the LM/Bc strain identified a single nucleotide polymorphism (SNP) in Gdf1 that may contribute to enhanced genetic susceptibility to FB1-induced NTDs; AKR/J mice have the same Gdf1 SNP and are also susceptible to FB1-NTDs. |FTY720 (Fingolimod, Gilenya®) is an FDA-approved drug used for treating multiple sclerosis. FTY720 treatment in pregnant mice caused NTDs in 40-60% of SWV and LM/Bc embryos and results in an accumulation of the bioactive ligand FTY720-P. Cytoplasmic Sa1P and FTY720-P function as agonists for sphingosine-1-phosphate (S1P) receptors, whereas nuclear Sa1P and FTY720-P inhibit histone deacetylase (HDAC) activity.|FB1 treatment in LM/Bc MEFs caused significant accumulation of nuclear Sa1P, decreased HDAC activity, and increased histone acetylation, suggesting that HDAC inhibition may represent a novel mechanism for FB1-induced NTDs. FB1 treatment also results in increased Gdf1 mRNA expression and increased miR-574-5p expression, a known regulator of CerS1 mRNA stability in the bicistronic transcript. Detection of the Gdf1 SNP and enhanced mir-574-5p expression may represent new genetic and epigenetic biomarkers for identifying individuals at risk for FB1-induced NTDs. |FTY720 treatment in LM/Bc MEFs resulted in elevated nuclear and cytoplasmic FTY720-P, suggesting that both HDAC inhibition and S1P receptor activation may play a role in FTY720-induced NTDs. As pharmacological applications for FTY720 expand, these studies provide mechanistic insight into the potential risks for use in pregnant women.
Description
Citation
Publisher
Creighton University
License
Copyright is retained by the Author. A non-exclusive distribution right is granted to Creighton University and to ProQuest following the publishing model selected above.
Copyright is retained by the Author. A non-exclusive distribution right is granted to Creighton University and to ProQuest following the publishing model selected above.
Copyright is retained by the Author. A non-exclusive distribution right is granted to Creighton University and to ProQuest following the publishing model selected above.